Jan 032023
 
Drug Name
Active Ingredient(s)
Approval Date
FDA-Approved Use on Approval Date
Press Release
Drug Trials Snapshot
NexoBrid anacaulase-bcdb 12/28/2022 To remove eschar in adults with deep partial thickness or full thickness thermal burns Drug Trials Snapshot
Briumvi ublituximab-xiiy 12/28/2022 To treat relapsing forms of multiple sclerosis Drug Trials Snapshot 
Xenoview hyperpolarized Xe-129 12/23/2022 To evaluate pulmonary function and imaging Drug Trials Snapshot
Lunsumio mosunetuzumab-axgb 12/22/2022 To treat adults with relapsed or refractory follicular lymphoma, a type of non-Hodgkin lymphoma Drug Trials Snapshot
Sunlenca lenacapavir 12/22/2022 To treat adults with HIV whose HIV infections cannot be successfully treated with other available treatments due to resistance, intolerance, or safety considerations Press Release Drug Trials Snapshot
Krazati adagrasib 12/12/2022 To treat KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer in adults who have received at least one prior systemic therapy Drug Trials Snapshot
Rezlidhia olutasidenib 12/1/2022 To treat adults with relapsed or refractory acute myeloid leukemia with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation Drug Trials Snapshot

Sorry, the comment form is closed at this time.